Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
CoJourney logo — Reimagining Cell and Gene Therapy CDMO Services High Purity...

CoJourney

Reimagining Cell and Gene Therapy CDMO Services High Purity | High Yield | Rapid Turnaround | Reduced Cost

Founded 2021 United States Philadelphia, United States 7 employees Series A Total: $30.00M Biopharma, Health Care +1

General Information

Company Name CoJourney
Founded Year 2021
Location United States Philadelphia, United States
Employees 7
Industries Biopharma, Health Care, Pharmaceutical
Funding Stage Series A
Business Model B2B, Platform, SaaS
Revenue Model Service Fee, Usage Based, Project Based
Social

BounceWatch is an independent company data service, not affiliated with CoJourney. To contact CoJourney, visit cojourney.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CoJourney compare?

A PDF of CoJourney and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CoJourney soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CoJourney

CoJourney, founded in 2021 and headquartered in the United States, is reimagining the cell and gene therapy CDMO services globally. Operating within the Biopharma, Health Care, and Pharmaceutical industries, CoJourney emphasizes innovation, sustainability, and cost-effectiveness in its operations.

The company's platform offers high-purity, high-yield, and rapid turnaround solutions for process development, clinical, and commercial manufacturing. Utilizing cutting-edge platform technologies, including Plasmids, mRNA, and various viral vectors such as AAV and Lentivirus, CoJourney ensures compliance with regulatory standards set by the US FDA, EU EMA, and China NMPA.

The company is currently producing AAV-based gene therapies for clinical trials, targeting conditions like Neurovascular Age-Related Macular Degeneration and Spinal Muscular Atrophy.

CoJourney recently secured a $30.00M Series A investment on June 27, 2023, from investors including Legend Star and Hillhouse Ventures, showing strong market confidence in its innovative approaches and growth potential.

Business keywords: Cell and Gene Therapy, CDMO Services, High Purity Manufacturing, High Yield Processes, Cost-Effective Solutions, Plasmid Production, Viral Vector Manufacturing, cGMP Compliance, mRNA Development, AAV Gene Therapy, Lentivirus Production, Retrovirus Manufacturing, Custom Viral Vectors, Analytical Development, Clinical Trial Manufacturing

Services & Products

Plasmid Manufacturing
Viral Vectors Manufacturing
sgRNA GMP Production
Exosome Manufacturing
Process Development
Analytical Testing and QC
GMP Manufacturing

Target Customers

Gene Therapy Companies Biopharmaceutical Developers Researchers in Cell and Gene Therapy

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $30.00M 8
Legend Star Legend Capital Lake Bleu Capital (Hong Kong) Limited
Legend Star, Legend Capital +6
27 Jun 2023

CoJourney Alternatives & Competitors

View All Alternatives
CoJourney vs
ProBio
ProBio United States

Manufacturing Life-Changing Therapies

Series C
246 employees
Biopharma, Biotechnology
CoJourney vs
IDT Biologika
IDT Biologika Germany

Your full-service CDMO for viral vaccines, cell & gene therapeutics and other biologics protecting h...

502 employees
Health Care, Manufacturing
CoJourney vs
GenScript ProBio
GenScript ProBio

A comprehensive R&D and production platform offering complete solutions for cell and gene therapy, v...

Series C
1001-5000 employees
Biopharma, Pharmaceutical
View all alternatives

FAQ About CoJourney

Reimagining Cell and Gene Therapy CDMO Services High Purity | High Yield | Rapid Turnaround | Reduced Cost
CoJourney was founded in 2021.
CoJourney is headquartered in Philadelphia, United States.
CoJourney operates in Biopharma, Health Care and Pharmaceutical. Its work centres on Cell and Gene Therapy, CDMO Services, High Purity Manufacturing and High Yield Processes. Its customers include Gene Therapy Companies, Biopharmaceutical Developers and Researchers in Cell and Gene Therapy.
CoJourney has a B2B, Platform and SaaS business model. Its revenue comes from Service Fee, Usage Based and Project Based.
CoJourney has approximately 7 employees.
CoJourney has completed 1 funding round, raising a total of $30.00M. The latest funding stage is Series A.
CoJourney offers: Plasmid Manufacturing, Viral Vectors Manufacturing, sgRNA GMP Production, Exosome Manufacturing, Process Development, Analytical Testing and QC, GMP Manufacturing.
Top alternatives and competitors to CoJourney include ProBio, IDT Biologika, GenScript ProBio, Chime Biologics, Charles River Laboratories. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CoJourney and ProBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CoJourney, https://bouncewatch.com/company/cojourney, updated 4 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes